CAT vs FDMT · P/E 48, rev $20.54B vs rev $37.0K
Caterpillar Inc (CAT) versus 4D Molecular Therapeutics Inc (FDMT) — a side-by-side from cached financials, not a winner call.
Caterpillar Inc (CAT) is a farm & heavy construction machinery company listed on NYSE. It is led by Jim Umpleby.
4D Molecular Therapeutics Inc (FDMT) is a biotechnology company listed on US.
Latest reported CAT revenue for 2026-06-30 was $20.54B. Net income was $3.59B. Revenue was up 18.0% from 2026-03-31 to 2026-06-30. CAT currently screens at market cap $440.29B and trailing P/E 47.7.
Latest reported FDMT revenue for 2024-12-31 was $37.0K. Net income was -$160.9M. Revenue was down 99.8% from 2023-12-31 to 2024-12-31. FDMT currently screens at market cap $518.1M.
CAT currently screens at market cap $440.29B and trailing P/E 47.7. FDMT currently screens at market cap $518.1M.
Not investment advice. Open the CAT and FDMT stock pages for the full models.
Not investment advice.